16232 Federal Register / Vol. 77, No. 54 / Tuesday, March 20, 2012 / Notices 

Dated: February 7, 2012. 

Nicole Lurie, 

Assistant Secretary for Preparedness and 

Response. 

[FR Doc. 2012–6608 Filed 3–19–12; 8:45 am] 

BILLING CODE 4150–37–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Advisory Committee to the Director, 

Centers for Disease Control and 

Prevention: Notice of Charter Renewal 

This gives notice under the Federal 

Advisory Committee Act (Pub. L. 92– 

463) of October 6, 1972, that the 

Advisory Committee to the Director, 

Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS), has been 

renewed for a 2-year period through 

February 1, 2014. 

For information, contact Carmen 

Villar, M.S.W., Designated Federal 

Officer, Advisory Committee to the 

Director, CDC, HHS, 1600 Clifton Road, 

NE., Mailstop D–14, Atlanta, Georgia 

30333, telephone 404/639–7000 or fax 

404/639–7111. 

The Director, Management Analysis 

and Services Office, has been delegated 

the authority to sign Federal Register 

notices pertaining to announcements of 

meetings and other committee 

management activities, for both the 

Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Dated: March 13, 2012. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. 2012–6637 Filed 3–19–12; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Advisory Committee on Breast Cancer 

in Young Women (ACBCYW) 

In accordance with section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC), 

announces the following meeting of the 

aforementioned committee: 

DATES: Times and Dates: 

12 p.m.–5 p.m., April 18, 2012, 

9 a.m.–5 p.m., April 19, 2012, 

8 a.m.–12 p.m., April 20, 2012. 

Place: Atlanta Marriott Perimeter 

Center, 246 Perimeter Center Parkway 

NE., Atlanta, Georgia 30346. 

Status: Open to the public, limited 

only by the space available. 

Purpose: The committee provides 

advice and guidance to the Secretary, 

HHS; the Assistant Secretary for Health; 

and the Director, CDC, regarding the 

formative research, development, 

implementation and evaluation of 

evidence-based activities designed to 

prevent breast cancer (particularly 

among those at heightened risk) and 

promote the early detection and support 

of young women who develop the 

disease. The advice provided by the 

Committee will assist in ensuring 

scientific quality, timeliness, utility, and 

dissemination of credible appropriate 

messages and resource materials. 

Matters To Be Discussed: The agenda 

will include discussions on approaches 

to increase awareness of clinicians/ 

practitioners regarding topics such as 

breast health, symptoms, diagnosis, and 

treatment of breast cancer in young 

women; and information needs and 

delivery mechanisms for women at 

higher risks for developing breast 

cancer. 

Agenda items are subject to change as 

priorities dictate. 

Online Registration Required: All 

ACBCYW attendees must register for the 

meeting online in advance at http:// 

www.cdc.gov/cancer/breast/ 

what_cdc_is_doing/meetings.htm. 

Please complete all the required fields 

before submitting your registration and 

submit no later than April 3, 2012. 

CONTACT PERSON FOR MORE INFORMATION: 

Temeika L. Fairley, Ph.D., Designated 

Federal Officer, National Center for 

Chronic Disease Prevention and Health 

Promotion, CDC, 5770 Buford Hwy, NE., 

Mailstop K52, Atlanta, Georgia 30341, 

Telephone (770) 488–4518, Fax (770) 

488–4760, Email: acbcyw@cdc.gov 

The Director, Management Analysis 

and Services Office, has been delegated 

the authority to sign Federal Register 

notices pertaining to announcements of 

meetings and other committee 

management activities, for both the 

Centers for Disease Control and 

Prevention, and Agency for Toxic 

Substances and Disease Registry. 

Dated: March 13, 2012. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. 2012–6641 Filed 3–19–12; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Disease, Disability, and Injury 

Prevention and Control Special 

Emphasis Panel (SEP): A Pilot 

Surveillance for High Impact/Low 

Prevalence Congenital and Inherited 

Conditions, FOA DD12–002, Initial 

Review 

In accordance with Section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC) 

announces the aforementioned meeting: 

Time and Date: 11 a.m.–5 p.m., April 17, 

2012 (Closed). 

Place: Teleconference. 

Status: The meeting will be closed to the 

public in accordance with provisions set 

forth in Section 552b(c)(4) and (6), Title 5 

U.S.C., and the Determination of the Director, 

Management Analysis and Services Office, 

CDC, pursuant to Public Law 92–463. 

Matters to be Discussed: The meeting will 

include the initial review, discussion, and 

evaluation of applications received in 

response to ‘‘A Pilot Surveillance for High 

Impact/Low Prevalence Congenital and 

Inherited Conditions, FOA DD12–002, initial 

review.’’ 

Contact Person for More Information: M. 

Chris Langub, Ph.D., Scientific Review 

Officer, CDC, 4770 Buford Highway, NE., 

Mailstop F–46, Atlanta, Georgia 30341, 

Telephone: (770) 488–3585. 

The Director, Management Analysis and 

Services Office, has been delegated the 

authority to sign Federal Register notices 

pertaining to announcements of meetings and 

other committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Dated: March 13, 2012. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. 2012–6640 Filed 3–19–12; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. FDA–2012–N–0253] 

Agency Information Collection 

Activities: Proposed Collection; 

Comment Request; Postmarketing 

Adverse Drug Experience Reporting 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice. 


srobinson on DSK4SPTVN1PROD with NOTICES